Clinical Trial Update: Cannabidiol for Treatment Resistant Depression [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating cannabidiol for treatment resistant depression was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Treatment Resistant Depression | Phase 4 | Status: WITHDRAWN